This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Aug 16;367(7):669-71.

doi: 10.1056/NEJMe1207165.

Quality of life and guidelines for PSA screening

PMID: 22894580
DOI: 10.1056/NEJMe1207165

Editorial

Quality of life and guidelines for PSA screening

Harold C Sox. N Engl J Med. 2012.

. 2012 Aug 16;367(7):669-71.

doi: 10.1056/NEJMe1207165.

Author

PMID: 22894580
DOI: 10.1056/NEJMe1207165

No abstract available

PubMed Disclaimer

Comment on

Quality-of-life effects of prostate-specific antigen screening.
Heijnsdijk EA, Wever EM, Auvinen A, Hugosson J, Ciatto S, Nelen V, Kwiatkowski M, Villers A, Páez A, Moss SM, Zappa M, Tammela TL, Mäkinen T, Carlsson S, Korfage IJ, Essink-Bot ML, Otto SJ, Draisma G, Bangma CH, Roobol MJ, Schröder FH, de Koning HJ. Heijnsdijk EA, et al. N Engl J Med. 2012 Aug 16;367(7):595-605. doi: 10.1056/NEJMoa1201637. N Engl J Med. 2012. PMID: 22894572 Free PMC article.

Similar articles

Quality-of-life effects of prostate-specific antigen screening.
Nagata M, Tanimoto T, Kami M. Nagata M, et al. N Engl J Med. 2012 Nov 8;367(19):1861-2; author reply 1862. doi: 10.1056/NEJMc1211071. N Engl J Med. 2012. PMID: 23134392 No abstract available.
Quality-of-life effects of prostate-specific antigen screening.
Haines IE. Haines IE. N Engl J Med. 2012 Nov 8;367(19):1861; author reply 1862. doi: 10.1056/NEJMc1211071. N Engl J Med. 2012. PMID: 23134391 No abstract available.
Prostate-specific antigen testing and prostate cancer screening.
Djavan B, Eckersberger E, Finkelstein J, Sadri H, Taneja SS, Lepor H. Djavan B, et al. Prim Care. 2010 Sep;37(3):441-59, vii. doi: 10.1016/j.pop.2010.05.001. Prim Care. 2010. PMID: 20705192 Review.
Screening for prostate cancer remains controversial.
Stark JR, Mucci L, Rothman KJ, Adami HO. Stark JR, et al. BMJ. 2009 Sep 24;339:b3601. doi: 10.1136/bmj.b3601. BMJ. 2009. PMID: 19778971 No abstract available.
PSA in screening for prostate cancer: more good than harm or more harm than good?
Duffy MJ. Duffy MJ. Adv Clin Chem. 2014;66:1-23. Adv Clin Chem. 2014. PMID: 25344984 Review.

See all similar articles

Cited by

Simultaneous Thoracic Spine Metastatic Melanoma and Pre-existing Prostate Adenocarcinoma: A Unique Case Presentation and Literature Review.
Venkata SA, Hakobyan N, Yadav R, Pokhrel A, Jamal F, Oudit O, Boris A, Kay A. Venkata SA, et al. Cureus. 2023 Aug 13;15(8):e43429. doi: 10.7759/cureus.43429. eCollection 2023 Aug. Cureus. 2023. PMID: 37706116 Free PMC article.
The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer.
Xiang Q, Zhu Z, Luo L, Wang J, Liu Y, Deng Y, Zhou M, Zhao Z. Xiang Q, et al. Biomed Res Int. 2020 Sep 24;2020:5395312. doi: 10.1155/2020/5395312. eCollection 2020. Biomed Res Int. 2020. PMID: 33029516 Free PMC article.
Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer.
Liu JB, Yan YJ, Shi J, Wu YB, Li YF, Dai LF, Ma XT. Liu JB, et al. Medicine (Baltimore). 2019 Jul;98(29):e16193. doi: 10.1097/MD.0000000000016193. Medicine (Baltimore). 2019. PMID: 31335671 Free PMC article.
A Patient-Centered Approach to Comparative Effectiveness Research Focused on Older Adults: Lessons From the Patient-Centered Outcomes Research Institute.
Mason NR, Sox HC, Whitlock EP. Mason NR, et al. J Am Geriatr Soc. 2019 Jan;67(1):21-28. doi: 10.1111/jgs.15655. Epub 2018 Dec 26. J Am Geriatr Soc. 2019. PMID: 30586155 Free PMC article.
Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models.
Alagoz O, Berry DA, de Koning HJ, Feuer EJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, Trentham-Dietz A, Mandelblatt JS; CISNET Breast Cancer Working Group members. Alagoz O, et al. Med Decis Making. 2018 Apr;38(1_suppl):3S-8S. doi: 10.1177/0272989X17737507. Med Decis Making. 2018. PMID: 29554472 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal